Most recent
CLSI C43-A2 Vol. 30 No. 6
Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline - Second Edition
This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.This document is no longer being reviewed as part of our consensus process. However, because of its usefulness to a limited segment of the healthcare community, we are continuing to make the document available for its informational content.
- ADD TO ALERT |
- PDF |
Clinical And Laboratory Standards Institute [clsi]
